Intracellular immunization of prokaryotic cells against a bacteriotoxin

Journal of Bacteriology

Volumn 180, Issue 3, 1998, Pages 514-518

  Chames, Patrick ^a   Fieschi, Jacques ^a,b   Baty, Daniel ^a   Duché, Denis ^a  

^a Inst Biol Developpment Marseille   (France)

^b Immunotech   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; COLICIN A;

AMINO TERMINAL SEQUENCE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNIZATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TOXIN ANALYSIS;

EID: 0031936581     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.180.3.514-518.1998     Document Type: Article

References (33)

1. Artsaenko, O., M. Peisker, U. zur Nieden, U. Fiedler, E. W. Weiler, K. Muntz, and U. Conrad. 1995. Expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco. Plant J. 8:745-750.
2. Barbas, C. F., III, T. A. Collet, W. Amberg, P. Roben, J. M. Binley, D. Hoekstra, D. Cababa, T. M. Jones, R. A. Williamson, G. R. Pilkington, et al. 1993. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230:812-823.
3. Bardwell, J. C., K. McGovern, and J. Beckwith. 1991. Identification of a protein required for disulfide bond formation in vivo. Cell 67:581-589.
4. Baty, D., M. Frenette, R. Lloubès, V. Géli, S. P. Howard, F. Pattus, and C. Lazdunski. 1988. Functional domains of colicin A. Mol. Microbiol. 2:807-811.
5. Bénédetti, H., C. Lazdunski, and R. Lloubès. 1991. Protein import into Escherichia coli: colicins A and E1 interact with a component of their translocation system. EMBO J. 10:1989-1995.
6. Bénédetti, H., R. Lloubès, C. Lazdunski, and L. Letellier. 1992. Colicin A unfolds during its translocation in Escherichia coli cells and spans the whole cell envelope when its pore has formed. EMBO. J. 11:441-447.
7. Biocca, S., M. S. Neuberger, and A. Cattaneo. 1990. Expression and targeting of intracellular antibodies in mammalian cells. EMBO J. 9:101-108.
8. Bourdineaud, J. P., P. Boulanger, C. Lazdunski, and L. Letellier. 1990. In vivo properties of colicin A: channel activity is voltage dependent but translocation may be voltage independent. Proc. Natl. Acad. Sci. USA 87:1037-1041.
9. Bouveret, E., A. Rigal, C. Lazdunski, and H. Bénédetti. 1997. The N-terminal domain of colicin E3 interacts with TolB which is involved in the colicin translocation step. Mol. Microbiol. 23:909-920.
10. Brass, J. M., C. F. Higgins, M. Foley, P. A. Rugman, J. Birmingham, and P. B. Garland. 1986. Lateral diffusion of proteins in the periplasm of Escherichia coli. J. Bacteriol. 165:787-795.
11. Davies, J. K., and P. Reeves. 1975. Genetics of resistance to colicins in Escherichia coli K-12: cross-resistance among colicins of group A. J. Bacteriol. 123:102-117.
12. Duché, D., D. Baty, M. Chartier, and L. Letellier. 1994. Unfolding of colicin A during its translocation through the Escherichia coli envelope as demonstrated by disulfide bond engineering. J. Biol. Chem. 269:24820-24825.
13. Duché, D., L. Letellier, V. Géli, H. Bénédetti, and D. Baty. 1995. Quantification of group A colicin import sites. J. Bacteriol. 177:4935-4939.
14. Espesset, D., D. Duché, D. Baty, and V. Géli. 1996. The channel domain of colicin A is inhibited by its immunity protein through direct interaction in the Escherichia coli inner membrane. EMBO J. 15:2356-2364.
15. Foote, J., and G. Winter. 1992. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224:487-489.
16. Geli, V., R. Lloubes, S. A. Zaat, R. M. van Spaendonk, C. Rollin, H. Benedetti, and C. Lazdunski. 1993. Recognition of the colicin A N-terminal epitope 1C11 in vitro and in vivo in Escherichia coli by its cognate monoclonal antibody. FEMS Microbiol. 109:335-342.
17. Géli, V., and C. Lazdunski. 1992. An α-helical hydrophobic hairpin as a specific determinant in protein-protein interaction occurring in Escherichia coli colicin A and B immunity systems. J. Bacteriol. 174:6432-6437.
18. Géli, V., and H. Bénédetti. 1996. Colicin transport, channel formation and inhibition, p. 665-691. In A. Konings et al. (ed.), Handbook of biological physics, vol. 2. Elsevier Science, Amsterdam, The Netherlands.
19. Glockshuber, R., M. Malia, I. Pfitzinger, and A. Plückthun. 1990. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29:1362-1367.
20. Guihard, G., P. Boulanger, H. Bénédetti, R. Lloubès, M. Besnard, and L. Letellier. 1994. Colicin A and the Tol proteins involved in its translocation are preferentially located in the contact sites between the inner and outer membranes of Escherichia coli cells. J. Biol. Chem. 269:5874-5880.
21. Haber, E. 1992. Engineered antibodies as pharmacological tools. Immunol. Rev. 130:189-212.
22. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
23. Hobot, J. A., E. Carlemalm, W. Villiger, and E. Kellenberger. 1984. Periplasmic gel: new concept resulting from the reinvestigation of bacterial cell envelope ultrastructure by new methods. J. Bacteriol. 160:143-152.
24. Hoogenboom, H. R., J. D. Marks, A. D. Griffiths, and G. Winter. 1992. Building antibodies from their genes. Immunol. Rev. 130:41-68.
25. Johnson, S., and R. E. Bird. 1991. Construction of single-chain Fv derivative monoclonal antibodies and their production in Escherichia coli. Methods Enzymol. 203:88-99.
26. Knappik, A., and A. Plückthun. 1995. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng. 8:81-89.
27. Le Calvez, H., J. Fieschi, J. M. Green, N. Marchesi, J. Chauveau, and D. Baty. 1995. Paratope characterisation by structural modelling of two anticortisol single-chain variable fragments produced in E. coli. Mol. Immunol. 32:185-198.
28. Marasco, W. A., W. A. Haseltine, and S. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90:7889-7893.
29. Mullinax, R. L., E. A. Gross, J. R. Amberg, B. N. Hay, H. H. Hogrefe, M. M. Kubitz, A. Greener, M. Alting-Mees, D. Ardourel, J. M. Short, et al. 1990. Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc. Natl. Acad. Sci. USA 87:8095-8099.
30. Plückthun, A. 1991. Antibody engineering: advances from the use of Escherichia coli expression systems. Bio/Technology 9:545-551.
31. Riechmann, L., M. Weill, and J. Cavanagh. 1992. Improving the antigen affinity of an antibody Fv-fragment by protein design. J. Mol. Biol. 224:913-918.
32. Tavladoraki, P., E. Benvenuto, S. Trinca, D. De Martinis, A. Cattaneo, and P. Galeffi. 1993. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366:469-472.
33. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature 349:293-299.